Drug Information
Drug General Information | |||||
---|---|---|---|---|---|
Drug ID |
D04IBH
|
||||
Former ID |
DNC005721
|
||||
Drug Name |
3-(5-Bromo-6-methoxy-naphthalen-2-yl)-pyridine
|
||||
Drug Type |
Small molecular drug
|
||||
Indication | Discovery agent | Investigative | [527801] | ||
Structure |
Download2D MOL |
||||
Formula |
C16H12BrNO
|
||||
Canonical SMILES |
COC1=C(C2=C(C=C1)C=C(C=C2)C3=CN=CC=C3)Br
|
||||
InChI |
1S/C16H12BrNO/c1-19-15-7-5-12-9-11(4-6-14(12)16(15)17)13-3-2-8-18-10-13/h2-10H,1H3
|
||||
InChIKey |
ZVOWEWSHEFYCIY-UHFFFAOYSA-N
|
||||
PubChem Compound ID | |||||
Target and Pathway | |||||
Target(s) | Cytochrome P450 11B1, mitochondrial | Target Info | Inhibitor | [527801] | |
Cytochrome P450 19 | Target Info | Inhibitor | [527801] | ||
NetPath Pathway | FSH Signaling Pathway | ||||
PANTHER Pathway | Androgen/estrogene/progesterone biosynthesis | ||||
PathWhiz Pathway | SteroidogenesisPW000045:Androgen and Estrogen Metabolism | ||||
WikiPathways | Metapathway biotransformation | ||||
Oxidation by Cytochrome P450 | |||||
Metabolism of steroid hormones and vitamin D | |||||
Corticotropin-releasing hormoneWP702:Metapathway biotransformation | |||||
Tryptophan metabolism | |||||
Ovarian Infertility Genes | |||||
FSH signaling pathway | |||||
Integrated Breast Cancer Pathway | |||||
Phase 1 - Functionalization of compounds | |||||
References |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.